Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults
Clinical trial NCT01612000 · COMPLETED
Trial details
- NCT number
- NCT01612000
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.